0.6498

7.33% 0.0444

Ovid Therapeutics Inc (OVID)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$0.6054

Offen:

$0.658

24-Stunden-Volumen:

1.54M

Relative Volume:

1.14

Marktkapitalisierung:

$46.93M

Einnahmen:

$391.70K

Nettoeinkommen (Verlust:

$-52.34M

KGV:

-0.8664

EPS:

-0.75

Netto-Cashflow:

$-45.92M

1W Leistung:

+76.58%

1M Leistung:

+109.34%

6M Leistung:

-7.57%

1J Leistung:

-36.91%

1-Tages-Spanne:

$0.594

$0.6631

1-Wochen-Bereich:

$0.36

$0.6631

52-Wochen-Spanne:

$0.2425

$1.47

Ovid Therapeutics Inc Stock (OVID) Company Profile

Firmenname

Ovid Therapeutics Inc

Sektor

Healthcare (1165)

Branche

Biotechnology (654)

Telefon

212-776-4381

Adresse

441 NINTH AVENUE, 14TH FLOOR, NEW YORK, NY

Mitarbeiter

Twitter

@OvidRx

Nächster Verdiensttermin

2024-11-04

Neueste SEC-Einreichungen

OVID's Discussions on Twitter

Vergleichen Sie OVID mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
OVID Ovid Therapeutics Inc	0.66	28.22M	391.70K	-52.34M	-45.92M	-0.75
VRTX Vertex Pharmaceuticals Inc	469.22	121.30B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	556.93	61.60B	14.09B	4.50B	2.96B	39.28
ALNY Alnylam Pharmaceuticals Inc	324.74	41.17B	2.35B	-269.70M	-75.39M	-2.09
ARGX Argen X Se Adr	572.75	34.35B	2.58B	1.06B	-1.28B	16.33
ONC Beone Medicines Ltd Adr	294.55	27.29B	3.81B	-644.79M	-669.77M	-6.24

Ovid Therapeutics Inc Stock (OVID) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-06-18	Herabstufung	Oppenheimer	Outperform → Perform
2024-04-30	Eingeleitet	B. Riley Securities	Buy
2024-04-29	Eingeleitet	H.C. Wainwright	Buy
2024-04-05	Eingeleitet	Wedbush	Outperform
2023-12-21	Eingeleitet	BTIG Research	Buy
2023-10-13	Eingeleitet	Oppenheimer	Outperform
2021-04-20	Herabstufung	Cantor Fitzgerald	Buy → Neutral
2021-03-03	Herabstufung	RBC Capital Mkts	Outperform → Sector Perform
2020-12-02	Herabstufung	Citigroup	Buy → Neutral
2020-12-02	Herabstufung	JMP Securities	Mkt Outperform → Mkt Perform
2019-09-04	Eingeleitet	RBC Capital Mkts	Outperform
2018-04-20	Eingeleitet	Ladenburg Thalmann	Buy

Alle ansehen

Ovid Therapeutics Inc Aktie (OVID) Neueste Nachrichten

01:08 AM

July 2025's Top Penny Stocks To Watch - simplywall.st

01:08 AM

09:33 AM

What drives Ovid Therapeutics Inc. stock priceFree Capital Growth Strategies - printweek.in

09:33 AM

09:18 AM

Is Ovid Therapeutics Inc. a good long term investmentRapid wealth multiplication - jammulinksnews.com

09:18 AM

09:12 AM

What analysts say about Ovid Therapeutics Inc. stockPhenomenal returns - jammulinksnews.com

09:12 AM

08:56 AM

Ovid Therapeutics Stock Soars 13.88% on Investor Optimism - AInvest

08:56 AM

Jul 20, 2025

Ovid Therapeutics Inc. Stock Analysis and ForecastFree Predictions - Autocar Professional

Jul 20, 2025

Jul 19, 2025

Ovid Therapeutics (NASDAQ:OVID) Receives Average Rating of “Buy” from Analysts - Defense World

Jul 19, 2025

Ovid Therapeutics (NASDAQ:OVID) Stock Rating Upgraded by Wall Street Zen - Defense World

Jul 19, 2025

Jul 18, 2025

What makes Ovid Therapeutics Inc. stock price move sharplyFree Access to Community with 300% Return - beatles.ru

Jul 18, 2025

Jul 17, 2025

12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga

Jul 17, 2025

Ovid Therapeutics Surges 25% Amid Analyst Hype and Strategic Pipeline Progress - AInvest

Jul 17, 2025

Jul 15, 2025

Why Ovid Therapeutics Inc. stock attracts strong analyst attentionDaily Breakout Picks - Newser

Jul 15, 2025

How Ovid Therapeutics Inc. stock performs during market volatilityTop Rated Trade Entries - Newser

Jul 15, 2025

Ovid Therapeutics (NASDAQ:OVID) Stock Price Down 2% – Time to Sell? - Defense World

Jul 15, 2025

Jul 11, 2025

Balance Sheet Insights: Ovid Therapeutics Inc (OVID)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - DWinneX

Jun 17, 2025

Jun 15, 2025

Stoke Therapeutics: Impressive Pipeline And Big Backers - Seeking Alpha

Jun 15, 2025

Jun 13, 2025